COVID-19 Pandemic and Posttreatment Breast Cancer Surveillance and Outcomes

By afschroeder • July 18, 2025

Hahn EE, Eng S, Chen A, Haupt EC, Goodall S, Munoz-Plaza CE, Nguyen HQ, Gould MK, Ganz PA, Shen E. COVID-19 Pandemic and Posttreatment Breast Cancer Surveillance and Outcomes. JAMA Oncol. 2025 Jul 17. doi: 10.1001/jamaoncol.2025.1991. Epub ahead of print. PMID: 40674101.

Tags: Hematology/Oncology, Publications

Associations of neighborhood deprivation with breast cancer tumor genomics, targeted treatment use, and survival

Podany EL, Foffano L, Gerratana L, Medford AJ, Heater NK, Nicolò E, Tapiavala S, Pontolillo L, Putur A, Jaber DA, Clifton K, Katakam N, Addison[...]

L-Glutamine in combination with first-line gemcitabine and nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: an open-label, single-arm, phase 1 GlutaPanc trial

Gong J, Muranaka H, Choi SY, Tighiouart M, Bhute S, Aja ER, Jacobs JP, Stotland A, Van Eyk J, Elmadbouh OHM, Edderkaoui M, Tanaka S,[...]

Unmasking Factor XIII Deficiency: Recurrent Intracranial Hemorrhage Despite Normal Coagulation Studies

Ramesh K, Hui G, Shodiya M, Palaskas NJ. Unmasking Factor XIII Deficiency: Recurrent Intracranial Hemorrhage Despite Normal Coagulation Studies. Cureus. 2026 Jul 29;18(7):e113621. doi: 10.7759/cureus.113621.[...]